Silverlake Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $279K | Buy |
2,518
+6
| +0.2% | +$665 | 0.08% | 251 |
|
|
2025
Q1 | $281K | Buy |
2,512
+6
| +0.2% | +$672 | 0.11% | 199 |
|
|
2024
Q4 | $231K | Buy |
2,506
+7
| +0.3% | +$647 | 0.09% | 232 |
|
|
2024
Q3 | $210K | Buy |
+2,499
| New | +$210K | 0.08% | 252 |
|
|
2024
Q1 | – | Sell |
-2,583
| Closed | -$209K | – | 247 |
|
|
2023
Q4 | $209K | Buy |
+2,583
| New | +$209K | 0.12% | 210 |
|
|
2023
Q2 | – | Sell |
-2,906
| Closed | -$241K | – | 229 |
|
|
2023
Q1 | $241K | Buy |
2,906
+7
| +0.2% | +$581 | 0.15% | 169 |
|
|
2022
Q4 | $249K | Sell |
2,899
-494
| -15% | -$42.4K | 0.16% | 167 |
|
|
2022
Q3 | $209K | Buy |
3,393
+14
| +0.4% | +$864 | 0.14% | 179 |
|
|
2022
Q2 | $209K | Buy |
3,379
+14
| +0.4% | +$865 | 0.14% | 181 |
|
|
2022
Q1 | $200K | Sell |
3,365
-263
| -7% | -$15.6K | 0.11% | 209 |
|
|
2021
Q4 | $263K | Buy |
+3,628
| New | +$263K | 0.14% | 169 |
|